Evidence map›Paper›PMID 31974941›Full record

ReviewMolecular neurobiology2020

The Ubiquitin System: a Regulatory Hub for Intellectual Disability and Autism Spectrum Disorder.

Maria A Kasherman, Susitha Premarathne, Thomas H J Burne, Stephen A Wood, Michael Piper

Open access · greenAbstract readReview
PubMed Publisher
In one paragraph

Review in Molecular neurobiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. A De NovoInternational journal of molecular sciences · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Maria A KashermanGriffith Institute for Drug Discovery, Griffith University, Brisbane, Queensland, 4111, Australia.ORCID https://orcid.org/0000-0003-0169-7578
Susitha PremarathneGriffith Institute for Drug Discovery, Griffith University, Brisbane, Queensland, 4111, Australia.ORCID https://orcid.org/0000-0003-0018-5554
Thomas H J BurneThe Queensland Brain Institute, The University of Queensland, Brisbane, Queensland, 4072, Australia.ORCID https://orcid.org/0000-0003-3502-9789
Stephen A Wood *Griffith Institute for Drug Discovery, Griffith University, Brisbane, Queensland, 4111, Australia.ORCID https://orcid.org/0000-0002-2576-7457
Michael Piper *The School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland, 4072, Australia. m.piper@uq.edu.au.ORCID https://orcid.org/0000-0002-6759-2560
Griffith University · AUThe University of Queensland · AU

Funding

Simons Foundation Autism Research Initiative 527556
6 · The paper itself

Abstract

Intellectual disability (ID) and autism spectrum disorder (ASD) are two of the most common neurodevelopmental disorders. Both disorders are extremely heterogenous, and only ~ 40% of reported cases have so far been attributed to genetic mutations. Of the many cellular processes that are affected, the ubiquitin system (UbS) is of particular relevance in that it can rapidly regulate multiple signaling cascades simultaneously. The UbS is a post-translational modification process that revolves around the covalent attachment of a ubiquitin moiety to a substrate, thereby influencing different elements of protein biology, including trafficking, signal transduction, and degradation. Importantly, the UbS has been implicated in regulating multiple pathophysiological pathways related to ASD and ID. This review will discuss how the UbS acts as major signaling hub in the pathogenesis of ASD and ID, raising the prospect of treating broader patient cohorts by targeting the UbS as a common point of convergence of various mutations.

Indexed as

Protein Processing, Post-TranslationalAdolescentAutism Spectrum DisorderChildFemaleHumansIntellectual DisabilityMaleSignal TransductionTOR Serine-Threonine KinasesTransforming Growth Factor betaUbiquitinUbiquitinationUbiquitin-Protein Ligase ComplexesWnt Signaling PathwayMTOR protein, humanTOR Serine-Threonine KinasesTransforming Growth Factor betaUbiquitinUbiquitin-Protein Ligase ComplexesAutism spectrum disorderIntellectual disabilitymTORTGFβUSP9XWNT

Identifiers

PMID31974941
OpenAlexW3001342018

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.